Gland Pharma gets EIR for VSEZ Sterile Oncology Facility

08 Nov 2023 Evaluate

Gland Pharma has received Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) indicating closure of the inspection at the Company’s VSEZ Sterile Oncology Facility at Visakhapatnam. The ‘Good Manufacturing Practice (GMP) Inspection’ was conducted by USFDA between July 20, 2023 and July 28, 2023.

Gland Pharma develops, manufactures and markets complex injectables. The company sells its products primarily under a business-to-business model in many countries.


Gland Pharma Share Price

1821.00 -15.25 (-0.83%)
20-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1724.45
Dr. Reddys Lab 1280.30
Cipla 1341.45
Zydus Lifesciences 901.00
Lupin 2219.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×